Potential Side Effects of Cagrilintide Therapy PEP DOSE What is cagrilintide (glucagon like peptide 1 receptor agonist) used for in the management of type 2 diabetes and obesity? Comparative Efficacy and Safety of Semaglutide, Cagrilintide, and CagriSema in Adults with Overweight or Obesity: A Bayesian Network Meta Analysis Journal of Clinical Question REDEFINE 1 Trial Finds CagrilintideSemaglutide Combo Delivers Over 20% Weight Loss in Majority of Patients Applied Clinical Trials Online Structural and dynamic features of cagrilintide binding to calcitonin and amylin receptors Nature Communications